vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in vTv Therapeutics Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +9 vs. Q4 2025
- Shares held
- 1.49M
- +287.1K (+23.9%) vs. Q4 2025
- Total value
- $59.0M
- +$11.0M (+22.9%) vs. Q4 2025
- New holders
- 12
- 7 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strategic Wealth Partners, Ltd. | 1 | $40 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $79 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 2 | $79 | 0.00% | +2 | New |
| BNP Paribas Arbitrage, SA | 9 | $357 | 0.00% | 00.0% | Unchanged |
| Sunbelt Securities, Inc. | 15 | $595 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 36 | $1.43K | 0.00% | +36 | New |
| Parallel Advisors, LLC | 38 | $1.51K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 45 | $1.78K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 50 | $1.98K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 43 | $2.00K | 0.00% | +43 | New |
| Bessemer Group Inc | 112 | $4.00K | 0.00% | 00.0% | Unchanged |
| Strengthening Families & Communities, LLC | 173 | $6.86K | 0.00% | +173 | New |
| Farther Finance Advisors, LLC | 283 | $11.5K | 0.00% | +4+1.4% | Added |
| Advisor Group Holdings, Inc. | 1,119 | $44.4K | 0.00% | −1−0.1% | Reduced |
| Morgan Stanley | 1,155 | $45.8K | 0.00% | +178+18.2% | Added |
| Vanguard Global Advisers, LLC | 1,275 | $50.6K | 0.00% | +1,275 | New |
| Qube Research & Technologies Ltd | 5,618 | $222.8K | 0.00% | +5,618 | New |
| UBS Group AG | 5,636 | $223.5K | 0.00% | +3,968+237.9% | Added |
| Pathstone Holdings, LLC | 6,073 | $240.9K | 0.00% | 00.0% | Unchanged |
| Brevan Howard Capital Management LP | 7,531 | $298.7K | 0.00% | +7,531 | New |
| State Street Corp | 10,666 | $423.0K | 0.00% | +10,666 | New |
| BlackRock, Inc. | 12,602 | $499.8K | 0.00% | +1,996+18.8% | Added |
| Goldman Sachs Group Inc | 13,350 | $529.5K | 0.00% | +7,819+141.4% | Added |
| Marshall Wace, LLP | 13,389 | $531.0K | 0.00% | +13,389 | New |
| 683 Capital Management, LLC | 16,000 | $634.6K | 0.06% | −2,268−12.4% | Reduced |
| Vanguard Fiduciary Trust Co | 16,126 | $639.6K | 0.00% | +16,126 | New |
| Northern Trust Corp | 18,052 | $715.9K | 0.00% | +2,000+12.5% | Added |
| Geode Capital Management, LLC | 32,886 | $1.31M | 0.00% | +4,692+16.6% | Added |
| Vanguard Capital Management LLC | 108,922 | $4.32M | 0.00% | +108,922 | New |
| Trails Edge Capital Partners, LP | 139,578 | $5.54M | 1.30% | −91,422−39.6% | Reduced |
| Baker Bros. Advisors LP | 148,314 | $5.88M | 0.03% | 00.0% | Unchanged |
| Siren, L.L.C. | 163,000 | $6.46M | 0.18% | 00.0% | Unchanged |
| Millennium Management LLC | 206,288 | $8.18M | 0.01% | +206,288 | New |
| FMR LLC | 260,391 | $10.3M | 0.00% | −8,465−3.1% | Reduced |
| Samsara BioCapital, LLC | 298,496 | $11.8M | 1.15% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,268−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |